The Patent Finder

Deuteria Pharmaceuticals, Inc.

Also on record
Records under this name other than the patents Deuteria Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.

Back to Deuteria Pharmaceuticals, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,531,685Deuterium-enriched oxybutynin
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 8,735,454Deuterium-Enriched Bupropion
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,925,175Deuterium-enriched pioglitazone
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 10,576,071Deuterium-enriched pioglitazone
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 10,940,143Deuterium-enriched pioglitazone
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 8,524,780Deuterium-Enriched Bupropion
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,918,567Deuterium-enriched pioglitazone
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 8,722,710Deuterium-enriched pioglitazone
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 9,090,5852,6-dioxo-3-deutero-piperdin-3-yl-isoindoline compounds
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 8,304,435Deuterium-enriched donepezil
Formerly held
Lapsed on the fee record
Ended Nov 6, 2024 · USPTO record
Lapsed on the fee recordEnded Nov 6, 2024USPTO record
10 of 20 patents shown.
Pro members see all 20.
Pro members: see all 20 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited